Results 41 to 50 of about 65,386 (216)
Background The Democratic Republic of the Congo (DRC) is one of the countries with the highest rotavirus mortality rate in the world. The aim of this study was to describe the clinical features of rotavirus infection after the introduction of rotavirus ...
Didier Gbebangi-Manzemu +10 more
doaj +1 more source
Secreted Nonstructural Protein 3 is a Pathogenic Determinant of Orbivirus
This study uncovers a conserved PIP2‐dependent secretory pathway of orbivirus NS3 that induces vascular leakage. Pharmacological disruption of PIP2‐NS3 interaction significantly reduces viral pathogenicity and provides protective efficacy in murine models, establishing PIP2‐mediated NS3 secretion as both a key virulence determinant and a promising ...
Junyong Guan +11 more
wiley +1 more source
Group A Rotavirus causes infectious, severe and dehydrating diarrhoea which has great impact on childhood morbidity and mortality worldwide. However, there are limited data on this subject matter in the study area.
Kaila, M. , Sarkinfada, F. , Yusuf, M.M.* , Musa, Y.I.
doaj
Aim Novel oral polio vaccine type 2 (nOPV2) was used under the WHO emergency use listing for circulating vaccine‐derived polio virus (cVDPV) outbreaks from 2021 to 2023. We assessed nOPV2 adverse events following immunization (AEFIs) and compared its safety profile to other vaccines using VigiBase.
Comfort Kunak Ogar +6 more
wiley +1 more source
A Numerical Guide to Volume 2 of the Guidelines and Practical Advice on how to Transpose them into National Standards [PDF]
[INTRODUCTION] In 2006, the World Health Organization published the third edition of the Guidelines, in collaboration with FAO and UNEP. The third edition consist of four volumes; volume 2, explained in this guidance note, addresses methods, procedures ...
Mara, D.D.
core
Scope for rotavirus vaccination in India: revisiting the scientific evidence.
Rotavirus vaccines have been developed to prevent deaths resulting from severe diarrhea of rotavirus origin. The use of vaccines as an intervention at scale to prevent and control the burden of rotavirus diarrhea is supported by the argument that ...
Hasan, Habib +3 more
core +1 more source
BackgroundAlthough rotavirus vaccination has reduced the global burden of the virus, morbidity and mortality from rotavirus infection remain high in Sub-Saharan Africa.
Didier Gbebangi Manzemu +12 more
doaj +1 more source
The economic burden of rotavirus infection in South Korea from 2009 to 2012.
Rotavirus is a common cause of diarrhea worldwide, and vaccination prevents rotaviral gastroenteritis. Since the rotavirus vaccine was introduced in Korea in 2007, the prevalence of rotaviral gastroenteritis has decreased. However, little is known on the
Kyung Suk Lee +3 more
doaj +1 more source
Trends in hospitalizations for vaccine‐preventable diseases in the United States from 2014 to 2024
Abstract Background and Objectives Vaccination rates have declined in recent years, resulting in outbreaks of vaccine‐preventable diseases (VPDs) among children. We aimed to evaluate VPD hospitalization rates from 2014 to 2024 and to report associated trends in outcomes including intensive care utilization, mortality, readmissions, and costs.
Nathan M. Money +5 more
wiley +1 more source
Quantifying health risks in wastewater irrigation [PDF]
The guidelines developed by the World Health Organization for the safe use of wastewater in agriculture are based on a tolerable additional disease burden of 10-6 disability-adjusted life year loss per person per year, equivalent to rotavirus disease and
Mara, D.D.
core

